Global Respiratory Diagnostics Market: Industry Analysis and Forecast (2020-2026) by Product and Services, Test, Diseases, Diseases, Sales Channel, and Region

Global Respiratory Diagnostics Market size was valued at US$ XX Mn in 2019 and is expected to reach US$ XX Mn by 2019 at a CAGR of 7.5% during the forecast period. The Global Respiratory Diagnostics market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The Global Respiratory Diagnostics report also provides trends by market segments, Diseases, and investment with a competitive landscape. Global Respiratory Diagnostics Market To know about the Research Methodology :- Request Free Sample Report

Global Respiratory Diagnostics Market Overview:

Respiratory disease testing includes various tests that are carried out to identify the cause of the disease. Test like Bronchoscopy, Chest Tube Procedure, CT Scan, CT Scan-Guided Lung Biopsy, Endobronchial Ultrasound (EBUS), Exhaled Nitric Oxide Test, Lobectomy, Lung Function Tests, and various others. This test is performed on the lungs and identifies the infected area by bacteria, fungi, or pathogens.

Global Respiratory Diagnostics Market Dynamics:

Rising pollution in the environment is boosting the market of respiratory diagnosis market. People around the globe have inculcated various bad habits that infect lungs and destroy them internally at a low pace and with time it increases the severity of the disease. For example, smoking and drinking habits affect badly the human body. Moreover, in the US 80-90% of deaths are caused due to cigarette smoking and are added as a major risk factor to the lung. Further, 90% of deaths are occurred in low and middle-income countries due to COPD. Besides, the growing advances in technological investment and in-vitro diagnostic test with the new generation is further boosting the demand of global respiratory diagnostics market in the forecast period of 2020-2026. Additionally, growing awareness in an individual due to the digital market is fueling the market and the low purchasing power of an individual can hamper the growth of the market as the diagnostic test are expensive and middle-class families cannot afford this Moreover, the installation of diagnostic devices in multispecialty hospitals and private hospitals, healthcare centers, and government initiatives like healthcare programs is further boosting the market of respiratory diagnostics in the forecast period.

Instrument and device are dominating the product and service segment of the Respiratory Diagnostics Market:

The instrument and device segment has gained more attention in the forecast period due to innovation and rapid technological investment in the market. Devices like multi-purpose imaging machines like CT scans and X-Ray, ultrasound imaging, MRI system, nuclear imaging system, and mammography imaging system. CT scans, X-rays have accounted for a major market share in the forecast period of 2020-2026. Due to the clear appearance of infected areas in the lungs and precise diagnosis. Moreover, The X-ray market was valued at 13.22 billion with a CAGR of 4.7% in the year 2020. The instrument and device segment is growing at a rapid pace due to growing industrialization and development in countries is further motivating the market to increase the investment in machinery.

The tuberculosis segment is expected to trend in the diseases segment of the Respiratory Diagnostics Market Demand:

The global tuberculosis segment is dominating the diseased segment of the respiratory diagnostic market due to the high prevalence of diseases in the world population. There are two types of tuberculosis active tuberculosis and latent tuberculosis. In 2019, 1.76 billion people were affected by tuberculosis that is 26% of the total world population. Moreover, Tuberculosis is also leading in terms of infectious diseases and around 1.59 million lives are affected each year globally. Tuberculosis is most common in Africa, the West Pacific, Eastern Europe, further these regions have also accounted for limited resources due to low economic development. The Asia Pacific accounts for 58.1% of the market share in the tuberculosis therapeutics market in 2019. Global Respiratory Diagnostics Market

Hospital and Clinical laboratories are dominating the end-user segment of the Global Respiratory Diagnostics Market:

The demand for early diagnosis and the rising occurrence of chronic diseases is fueling the market of hospitals and clinics in the forecast period of 2020-2026. Rapid innovation in technology like multipurpose imaging machines to diagnose disease together with low-cost investment is likely to boost the market growth of clinical laboratories. The clinical laboratory market was valued at USD 203.3 billion in 2020 and is likely to grow at a 4.9% CAGR in the forecast period. North America is leading in the clinical laboratories market due to the adoption of new technologies and innovations. And accounted for 39% of the market share in 2020. Moreover, these technologies are software-based which offers precise diagnostic treatment Global Respiratory Disease Testing Market

Global Respiratory Diagnostics Market Regional Insights:

North America is dominating the respiratory diagnostics market due to the rising frequency of respiratory diseases like Chronic Obstructive Pulmonary Diseases (COPD) and asthma. North America is leading in the healthcare sector with market tread due to the adoption of new technologies and innovations. Moreover, these technologies are software-based which offers precise diagnostic treatment with no flaws. The dominating countries of North America are US., Mexico, and Canada. Further, the US has accounted for a major market share due to the presence of key market players in the region. The Asia Pacific is second dominating due to growing incipient markets for respiratory diagnostics to deliver improving health care infrastructure and to develop awareness among patients concerning the availability of diagnostic procedures and latest technologies. The major countries of Asia Pacific are China, Japan, and India offering huge revenue generation opportunities for the key players in the market and to grow with trends to generate profitable outcomes. Global Respiratory Disease Testing Market The objective of the report is to present a comprehensive analysis of the Global Respiratory Diagnostics Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Respiratory Diagnostics Market dynamics, structure by analyzing the market segments and project the Global Respiratory Diagnostics Market size. Clear representation of competitive analysis of key players by Type, price, financial position, Type portfolio, growth strategies, and regional presence in the Global Respiratory Diagnostics Market make the report investor’s guide

Global Respiratory Diagnostics Market Scope: Inquire before buying

Global Respiratory Disease Testing Market

Global Respiratory Diagnostics Market, by Region

• North America o US o Canada o Mexico • Europe o U.K o France o Germany o Italy o Spain o Sweden o CIS Countries o Rest of Europe • Asia Pacific o China o India o Japan o South Korea o Australia o ASEAN o Rest of Asia Pacific • The Middle East and Africa o South Africa o GCC Countries o Egypt o Nigeria o Rest of ME&A • South America o Brazil o Argentina o Rest of South America

Global Respiratory Diagnostics Market Key Players

• Koninklijke Philips N.V. • Medtronic • BD • COSMED srl • Abbott • F. Hoffmann-La Roche Ltd • NIHON KOHDEN CORPORATION • Drägerwerk AG & Co. KGaA • Bio-Rad Laboratories, Inc. • Thermo Fisher Scientific Inc. • MGC Diagnostics Corporation • Masimo • bioMérieux SA • Carestream Health • VYAIRE • Seegene Inc. • ResMed • SDI Diagnostics
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Respiratory Diagnostics Market Size , by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Respiratory Diagnostics Size Market 3.4. Geographical Snapshot of the Respiratory Diagnostics Market, By Manufacturer share 4. Global Respiratory Diagnostics Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Technologies 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Respiratory Diagnostics Market 5. Supply Side and Demand Side Indicators 6. Global Respiratory Diagnostics Market Analysis and Forecast, 2019-2026 6.1. Global Respiratory Diagnostics Market Size & Y-o-Y Growth Analysis. 7. Global Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 7.1.1. Instruments and Devices 7.1.2. Assays and Reagents 7.1.3. Services and Software 7.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 7.2.1. Traditional Diagnostic Tests 7.2.2. Mechanical Tests 7.2.3. Imaging Tests 7.2.4. Molecular Diagnostic Tests 7.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 7.3.1. Chronic Obstructive Pulmonary Disease 7.3.2. Lung Cancer 7.3.3. Asthma 7.3.4. Tuberculosis 7.3.5. Other Diseases 7.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 7.4.1. Hospital/Clinical Laboratories 7.4.2. Physician Offices 7.4.3. Reference Laboratories 7.4.4. Other End Users 8. Global Respiratory Diagnostics Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 9.1.1. Instruments and Devices 9.1.2. Assays and Reagents 9.1.3. Services and Software 9.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 9.2.1. Traditional Diagnostic Tests 9.2.2. Mechanical Tests 9.2.3. Imaging Tests 9.2.4. Molecular Diagnostic Tests 9.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 9.3.1. Chronic Obstructive Pulmonary Disease 9.3.2. Lung Cancer 9.3.3. Asthma 9.3.4. Tuberculosis 9.3.5. Other Diseases 9.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 9.4.1. Hospital/Clinical Laboratories 9.4.2. Physician Offices 9.4.3. Reference Laboratories 9.4.4. Other End Users 10. North America Respiratory Diagnostics Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 11.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 11.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 12. Canada Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 12.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 12.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 13. Mexico Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 13.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 13.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 14. Europe Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 14.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 14.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 15. Europe Respiratory Diagnostics Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 16.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 16.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 17. France Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 17.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 17.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 18. Germany Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 18.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 18.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 19. Italy Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 19.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 19.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 20. Spain Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 20.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 20.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 21. Sweden Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 21.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 21.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 22. CIS Countries Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 22.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 22.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 23. Rest of Europe Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 23.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 23.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 24. Asia Pacific Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 24.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 24.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 25. Asia Pacific Respiratory Diagnostics Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 26.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 26.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 27. India Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 27.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 27.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 28. Japan Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 28.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 28.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 29. South Korea Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 29.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 29.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 30. Australia Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 30.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 30.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 31. ASEAN Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 31.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 31.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 32. Rest of Asia Pacific Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 32.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 32.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 33. Middle East Africa Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 33.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 33.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 34. Middle East Africa Respiratory Diagnostics Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 35.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 35.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 36. GCC Countries Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 36.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 36.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 37. Egypt Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 37.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 37.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 38. Nigeria Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 38.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 38.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 39. Rest of ME&A Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 39.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 39.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 40. South America Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 40.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 40.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 41. South America Respiratory Diagnostics Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 42.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 42.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 43. Argentina Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 43.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 43.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 44. Rest of South America Respiratory Diagnostics Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Product and Services, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Test, 2019-2026 44.3. Market Size (Value) Estimates & Forecast By Diseases, 2019-2026 44.4. Market Size (Value) Estimates & Forecast By End-User, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Respiratory Diagnostics Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment, and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures, and Strategic Alliances/ Sales Agreements 45.3. Company Profile: Key Players 45.3.1. SDI Diagnostics 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Koninklijke Philips N.V. 45.3.3. Medtronic 45.3.4. BD 45.3.5. COSMED Srl 45.3.6. Abbott 45.3.7. F. Hoffmann-La Roche Ltd 45.3.8. NIHON KOHDEN CORPORATION 45.3.9. Drägerwerk AG & Co. KGaA 45.3.10. Bio-Rad Laboratories, Inc. 45.3.11. Thermo Fisher Scientific Inc. 45.3.12. MGC Diagnostics Corporation 45.3.13. Masimo 45.3.14. bioMérieux SA 45.3.15. Carestream Health 45.3.16. VYAIRE 45.3.17. Seegene Inc. 45.3.18. ResMed 46. Primary Key Insights

About This Report

Report ID112714
Category Healthcare
Published DateJul 2021
Updated Date
Contact Us